122 related articles for article (PubMed ID: 33259241)
21. Secondary malignant neoplasms in testicular cancer survivors.
Curreri SA; Fung C; Beard CJ
Urol Oncol; 2015 Sep; 33(9):392-8. PubMed ID: 26072728
[TBL] [Abstract][Full Text] [Related]
22. Reproductive hormones and metabolic syndrome in 24 testicular cancer survivors and their biological brothers.
Bandak M; Jørgensen N; Juul A; Lauritsen J; Kier MGG; Mortensen MS; Oturai PS; Mortensen J; Hojman P; Helge JW; Daugaard G
Andrology; 2017 Jul; 5(4):718-724. PubMed ID: 28598554
[TBL] [Abstract][Full Text] [Related]
23. Modifiable lifestyle behaviours impact the health-related quality of life of bladder cancer survivors.
Chung J; Kulkarni GS; Bender J; Breau RH; Guttman D; Maganti M; Matthew A; Morash R; Papadakos J; Jones JM
BJU Int; 2020 Jun; 125(6):836-842. PubMed ID: 31977152
[TBL] [Abstract][Full Text] [Related]
24. Second cancers among 40,576 testicular cancer patients: focus on long-term survivors.
Travis LB; Fosså SD; Schonfeld SJ; McMaster ML; Lynch CF; Storm H; Hall P; Holowaty E; Andersen A; Pukkala E; Andersson M; Kaijser M; Gospodarowicz M; Joensuu T; Cohen RJ; Boice JD; Dores GM; Gilbert ES
J Natl Cancer Inst; 2005 Sep; 97(18):1354-65. PubMed ID: 16174857
[TBL] [Abstract][Full Text] [Related]
25. Prevalence and correlates of smoking and cessation-related behavior among survivors of ten cancers: findings from a nationwide survey nine years after diagnosis.
Westmaas JL; Alcaraz KI; Berg CJ; Stein KD
Cancer Epidemiol Biomarkers Prev; 2014 Sep; 23(9):1783-92. PubMed ID: 25100826
[TBL] [Abstract][Full Text] [Related]
26. Prevalence of the metabolic syndrome and cardiovascular disease risk in chemotherapy-treated testicular germ cell tumour survivors.
Willemse PM; Burggraaf J; Hamdy NA; Weijl NI; Vossen CY; van Wulften L; van Steijn-van Tol AQ; Rosendaal FR; Osanto S
Br J Cancer; 2013 Jul; 109(1):60-7. PubMed ID: 23660945
[TBL] [Abstract][Full Text] [Related]
27. Nutritional interventions for survivors of childhood cancer.
Cohen JE; Wakefield CE; Cohn RJ
Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD009678. PubMed ID: 27545902
[TBL] [Abstract][Full Text] [Related]
28. Testicular-cancer survivors experience compromised language following chemotherapy: findings in a Swedish population-based study 3-26 years after treatment.
Skoogh J; Steineck G; Stierner U; Cavallin-Ståhl E; Wilderäng U; Wallin A; Gatz M; Johansson B;
Acta Oncol; 2012 Feb; 51(2):185-97. PubMed ID: 21851186
[TBL] [Abstract][Full Text] [Related]
29. A population-based estimate of the prevalence of behavioral risk factors among adult cancer survivors and noncancer controls.
Coups EJ; Ostroff JS
Prev Med; 2005 Jun; 40(6):702-11. PubMed ID: 15850868
[TBL] [Abstract][Full Text] [Related]
30. The prevalence and correlates of supportive care needs in testicular cancer survivors: a cross-sectional study.
Smith AB; King M; Butow P; Luckett T; Grimison P; Toner GC; Stockler M; Hovey E; Stubbs J; Hruby G; Gurney H; Turner S; Alam M; Cox K; Olver I
Psychooncology; 2013 Nov; 22(11):2557-64. PubMed ID: 23825010
[TBL] [Abstract][Full Text] [Related]
31. Prevalence of lifestyle characteristics in glucocorticoid users and non-users: a Danish population-based cross-sectional study.
Laugesen K; Petersen I; Pedersen L; Breinholt Larsen F; Jørgensen JOL; Sørensen HTT
BMJ Open; 2019 Oct; 9(10):e030780. PubMed ID: 31662378
[TBL] [Abstract][Full Text] [Related]
32. Aspects of posttraumatic stress disorder in long-term testicular cancer survivors: cross-sectional and longitudinal findings.
Dahl AA; Østby-Deglum M; Oldenburg J; Bremnes R; Dahl O; Klepp O; Wist E; Fosså SD
J Cancer Surviv; 2016 Oct; 10(5):842-9. PubMed ID: 26920871
[TBL] [Abstract][Full Text] [Related]
33. Treatment-specific risks of second malignancies and cardiovascular disease in 5-year survivors of testicular cancer.
van den Belt-Dusebout AW; de Wit R; Gietema JA; Horenblas S; Louwman MW; Ribot JG; Hoekstra HJ; Ouwens GM; Aleman BM; van Leeuwen FE
J Clin Oncol; 2007 Oct; 25(28):4370-8. PubMed ID: 17906202
[TBL] [Abstract][Full Text] [Related]
34. Early and late renal adverse effects after potentially nephrotoxic treatment for childhood cancer.
Knijnenburg SL; Mulder RL; Schouten-Van Meeteren AY; Bökenkamp A; Blufpand H; van Dulmen-den Broeder E; Veening MA; Kremer LC; Jaspers MW
Cochrane Database Syst Rev; 2013 Oct; (10):CD008944. PubMed ID: 24101439
[TBL] [Abstract][Full Text] [Related]
35. Adherence to multiple health behaviours in cancer survivors: a systematic review and meta-analysis.
Tollosa DN; Tavener M; Hure A; James EL
J Cancer Surviv; 2019 Jun; 13(3):327-343. PubMed ID: 30993648
[TBL] [Abstract][Full Text] [Related]
36. Thyroid hypofunction in aging testicular cancer survivors.
Nome RV; Småstuen MC; Fosså SD; Kiserud CE; Åsvold BO; Bjøro T
Acta Oncol; 2021 Nov; 60(11):1452-1458. PubMed ID: 34351829
[TBL] [Abstract][Full Text] [Related]
37. Smoking cessation prolongs survival in female cancer survivors - the Danish nurse cohort.
Heberg J; Simonsen MK; Thomsen T; Zoffmann V; Danielsen AK
Eur J Oncol Nurs; 2020 Aug; 47():101796. PubMed ID: 32682286
[TBL] [Abstract][Full Text] [Related]
38. Health-related quality of life in long-term survivors of testicular cancer.
Rossen PB; Pedersen AF; Zachariae R; von der Maase H
J Clin Oncol; 2009 Dec; 27(35):5993-9. PubMed ID: 19858403
[TBL] [Abstract][Full Text] [Related]
39. Fertility, gonadal and sexual function in survivors of testicular cancer.
Huddart RA; Norman A; Moynihan C; Horwich A; Parker C; Nicholls E; Dearnaley DP
Br J Cancer; 2005 Jul; 93(2):200-7. PubMed ID: 15999104
[TBL] [Abstract][Full Text] [Related]
40. Cardiovascular disease as a long-term complication of treatment for testicular cancer.
Huddart RA; Norman A; Shahidi M; Horwich A; Coward D; Nicholls J; Dearnaley DP
J Clin Oncol; 2003 Apr; 21(8):1513-23. PubMed ID: 12697875
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
